Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors
about
Early diagnostic protein biomarkers for breast cancer: how far have we come?Examining the significance of fingerprint-based classifiers.Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at RiskSELDI-TOF serum proteomics and colorectal cancer: a current overview.Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.Biomarkers for colorectal cancerModulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.Proteomic serum biomarkers and their potential application in cancer screening programs.A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control studySerum proteomic profiling for the early diagnosis of colorectal cancer.Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancerComparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening.A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva.Proteomic profiling of urine for the detection of colon cancer.Perspectives of clinical proteomics in gastrointestinal cancer.Failure of screening or failure to screen? The screening behavior of patients with colorectal cancer in the Leipzig area.Noninvasive screening tests for colorectal cancer.Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.The role of the complement system in cancer.Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohortsExpression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer.Early detection of recurrence after curative resection for colorectal cancer - obstacles when using soluble biomarkers?Complement in cancer: untangling an intricate relationship.
P2860
Q31043570-18350D4A-5D26-4098-8FFD-B22ACB857B27Q33394036-0B116837-EBFC-44C9-81EB-8677050EF2D0Q33439145-2A31D263-40D6-45E5-818C-E2D9437A78C8Q33478415-D32AEAD0-4DB7-4C15-AD81-8AD4193C347FQ33628047-55FC72A1-936D-45DE-B883-D69E8B40ABD3Q33892389-690D54EE-2E8D-49D8-8162-F558C13830A4Q34205596-BE2C984D-8362-48F0-B8D9-62FB60691848Q34256060-D8F16C00-518B-44BA-88EF-C9D9FD24F4D2Q34395996-1152C9A7-53D2-480F-86A6-A2D226125021Q34407192-31988398-68C3-4909-8630-AED3ECDFC9C5Q34409534-53D88315-4FC2-4C22-938B-BAF06C4D4A54Q34542024-832FC076-9610-4BC0-B8E9-AFA29C3F8A8DQ35889928-AF302E62-EB03-42CE-B68D-34680183C4C8Q36436952-0FBEB369-6C1A-4AA5-BE45-0308F14E63C8Q36736959-B33C88E7-7AD1-470B-B2BB-60A86BDEB6F0Q36788467-45ED491A-9A75-49E7-87C2-FF4E47C01B02Q37188123-50256CB5-1087-4776-BDCF-77A3F912F61DQ38064739-3A2E4DD3-813A-4895-AAD2-D188E6E20149Q38202166-CF49B015-0428-427D-AF51-19FE11E997CEQ38652227-A3988D37-7FD3-4929-8845-B9FDA6E13F05Q39156024-2648971B-7C1F-45FE-A91D-5F394E27A791Q41708805-BFC491E9-E245-45D8-91F8-CEE2DC870F11Q42553545-5FD1DF64-F184-407B-8B8F-5C46AF8AA2D6Q44844409-65806883-2010-4344-900E-D42C3CF6DC18Q50049007-D16ABE38-AED2-4935-A08E-DF7BC3064B6B
P2860
Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Increased serum levels of comp ...... presence of colorectal tumors
@ast
Increased serum levels of comp ...... presence of colorectal tumors
@en
type
label
Increased serum levels of comp ...... presence of colorectal tumors
@ast
Increased serum levels of comp ...... presence of colorectal tumors
@en
prefLabel
Increased serum levels of comp ...... presence of colorectal tumors
@ast
Increased serum levels of comp ...... presence of colorectal tumors
@en
P2093
P2860
P1433
P1476
Increased serum levels of comp ...... presence of colorectal tumors
@en
P2093
Brian T Luke
Darue A Prieto
Elisabeth Oevermann
Hans-Peter Bruch
Jens K Habermann
John M Roman
Michael Duchrow
Nils Homann
Stanley K Burt
P2860
P304
1020-9; quiz 1284
P356
10.1053/J.GASTRO.2006.07.011
P407
P577
2006-10-01T00:00:00Z